Viewing Study NCT00694603


Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2026-03-01 @ 6:01 AM
Study NCT ID: NCT00694603
Status: TERMINATED
Last Update Posted: 2012-09-06
First Post: 2007-12-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy
Sponsor: Lecia V. Sequist
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 06-026
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None INDUSTRY View